Recombinant Human Erythropoietin Alfa Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 2000 IU,3000 IU,4000 IU,5000 IU,6000 IU,10,000 IU & 40,000 IU

Reference Brands: Epogen, Procrit(US), Eprex(EU)

Category: Nephrology

Recombinant Human Erythropoietin Alfa Injection is available in Injection and strengths such as 2000 IU,3000 IU,4000 IU,5000 IU,6000 IU,10,000 IU & 40,000 IU. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Recombinant Human Erythropoietin Alfa Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Recombinant Human Erythropoietin Alfa Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Recombinant Human Erythropoietin Alfa Injection is a biologic therapy used to treat anemia associated with chronic kidney disease (CKD), cancer chemotherapy, and HIV treatment. It stimulates red blood cell production, reducing the need for blood transfusions. Commonly marketed as Epogen® and Procrit® in the US, and Eprex® in the EU, Erythropoietin Alfa is a vital medication in nephrology and oncology care. Available in prefilled syringes and vials, it comes in strengths ranging from 2,000 IU to 10,000 IU. Collaborate with WHO-GMP/EU-GMP certified manufacturers to supply high-quality erythropoietin injections for global Pharma B2B markets.